References
- Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005–16.
- Federal Ministry of Health. Malaria situation analysis document. Nigeria: Federal Ministry of Health; 2000.
- World Health Organization. Framework for developing, implementing and updating national antimalarial drug policy: a guide for country malaria control programmes. AFR/MAL/03.02. Brazzaville: WHO Regional Office for Africa; 2003.
- Enato EF, Mens PF, Okhamafe AO, Okpere EE, Schallig HD, Pogoson EE. Plasmodium falciparum malaria in pregnancy: prevalence of peripheral parasitaemia, anaemia, and malaria care-seeking behaviour among pregnant women attending antenatal clinics in Edo State, Nigeria. J Obstet Gynecol 2009;29:301–6.
- Mens PF, Scheelbeek PF, Al Atabbi H, Enato EF. Peer education: the effects on knowledge, and preventive practice of pregnancy related malaria in women of reproductive age in Edo State, Nigeria. BMC Public Health 2011; 11:610.
- National Malaria and Vector Control Division. National antimalarial treatment guidelines and policy. Abuja, Nigeria: Federal Ministry of Health; 2005.
- Mwangi TW, Mohammed M, Dayo H, Snow RW, Marsh K. Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Trop Med Int Health 2005; 10:530–6.
- Luxemburger C, Nosten F, Kyle DE, Kiricharoen L, Chongsuphajaisiddhi T, White NJ. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg 1998;92:45–9.
- Eze UI, Eferakeya AE, Oparah AC, Enato EF. Assessment of prescription profile of pregnant women visiting antenatal clinics. Pharm Pract (Internet) 2007;5:135–9.
- Abasiattai AM, Etukumana EA, Umoiyoho AJ. Awareness and practice of malaria prevention strategies among pregnant women in Uyo, South Nigeria. Internet J Gynecol Obstet 2009;11(1).
- Maubert B, Fievert N, Tami G, Cot M, Boudin C, Deloron P. Development of antibodies against chondroitin sulphate A-adherent Plasmodium falciparum in pregnant women. Infect Immun 1999;67:5367–71.
- Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulphate A. J Immunol 2000;165:3309–16.
- Ndyomugyenyi R, Neema S, Magnussen P. The use of formal and informal services for antenatal care and malaria treatment in rural Uganda. Health Policy Plan 1998;13:94–102.
- Sangaré LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A. Patterns of anti-malarial drug treatment among pregnant women in Uganda. Malar J 2011;10:152.
- Zurovac D, Njogu J, Akhawale W, Harmer DH, Larson BA, Snow RW. Effects of revised diagnostic recommendations in malaria treatment practice across age groups in Kenya. Trop Med Int Health J 2008;13:784–7.
- Bardají A, Sigauque B, Bruni L, Romagosa C, Sanz S, Mabunda S, et al. Clinical malaria in African pregnant women. Malar J 2008;7: 27.
- Mwanziva C, Shekalaghe S, Ndaro A, Mengerink B, Megiroo S, Mosha F, et al. Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J 2008;7:232.
- Okoro RN, Nwambu JO. Evaluation of physicians’ prescribing patterns of antimalarial drugs during pregnancy at the obstetrics and gynaecology department of a teaching hospital in Maiduguri, Borno State, Nigeria. Int J Pharm Biomed Sci 2012;3:39–46.
- World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva: WHO; 2010.
- National Malaria and Vector Control Division. National policy on malaria diagnosis and treatment for Nigeria (revised). Lagos, Nigeria: Federal Ministry of Health; 2011.